TransitionCHF aims to recruit a unique cohort of patients with asymptomatic left ventricular dysfunction (NYHA I) to study the progression to symptomatic (>NYHA I) HF and to identify parameters/ biomarkers promoting and predicting the individual risk of transition. Results from TransitionCHF Cohort Study will inform and refine current treatment guidelines. The implementation of common patient data sets and biobanking standards will enable data and biomaterial sharing with other DZHK study groups. This study will set the standard for a unique DZHK heart failure database and Biobank for innovative preclinical and clinical trials.
| Condition | Systolic Dysfunction, Transition, Heart Failure, Biobank, Systolic Dysfunction, Transition, Heart Failure, Biobank |
|---|---|
| Clinical Study Identifier | NCT02323750 |
| Sponsor | University of Göttingen |
| Last Modified on | 7 February 2023 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.